reviews the main statistical approaches for dose-finding in phase I/II clinical trials and presents practical guidance on their correct use. is an important collaboration from the leading experts in the area. Primarily aimed at statisticians and clinicians working in clinical trials and medical research, there is also much to benefit graduate students of biostatistics.